Search results
12 Unhealthiest Store-Bought Coleslaws
Mashed via Yahoo News· 2 days agoYou might not think twice about grabbing a container of coleslaw from the grocery store. Some brands offer cheaper options but have unhealthy...
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update
ETF DAILY NEWS· 8 hours agoENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 277,600 ...
Europe Needs Chinese Investment | by Dalia Marin - Project Syndicate
Project Syndicate· 9 hours agoOver the past two decades, the productivity gap between Europe and the United States has steadily...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 2 days agoEli Lilly stock is trading at a record high as enthusiasm grows for its Alzheimer's treatment,...
Ipsen shares maintain buy rating on drug data By Investing.com
Investing.com· 7 days agoOn Thursday, Citi reaffirmed its Buy rating and €130.00 stock price target for Ipsen SA (IPN:FP)...
Is Ozempic an Obesity Drug, or an Everything Drug?
The Atlantic· 2 days agoThere’s no such thing as a miracle cure for weight loss, but the latest obesity drugs seem to come pretty close. People who take Ozempic or other weekly...
I'm an ICU doctor. When I needed a liver transplant I learned how vulnerable it is to be a patient.
Business Insider· 2 days agoDonald Chalfin's wife made him take a blood test after he showed symptoms of being sick. He needed a...
Petri Dish: Ipsen’s drug approval; Discovery expands local footprint - Boston Business Journal
The Business Journals· 8 hours agoDrug approvals were at the center of two stories this week in the Petri Dish, as we dive into a...
Why vomiting blood could be a sign of severe health issues
Rolling Out· 2 days agoVomiting blood, medically known as hematemesis, is a serious symptom that indicates several...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...
Morningstar· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO) and reminds investors ...